GSK-180736-A

N/A

Report date: 2025/03/19 16:44:55
NME

Base Information

Drug NameGSK-180736-A
Drug Alias NameGSK-180736-AGSK-180736A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 1 inhibitorsBeta-adrenergic receptor kinase 1 inhibitors
TargetsRho-associated protein kinase 1Beta-adrenergic receptor kinase 1
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Michigan
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A